Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary:
- To compare the efficacy and safety of Insulin Glulisine to Insulin Lispro in subjects
with type 1 or type 2 diabetes mellitus.
- To compare the frequency of hypoglycemia of Insulin Glulisine to Insulin Lispro.
Secondary:
- To compare Insulin Glulisine to Insulin Lispro in terms of the change in HbA1c at weeks
12, blood glucose parameters, insulin doses and treatment satisfaction in subjects with
type 1 or type 2 diabetes mellitus